Stay updated with breaking news from Solid Biosciences Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Equities research analysts at Leerink Partnrs raised their Q3 2023 earnings per share (EPS) estimates for Solid Biosciences in a research note issued to investors on Wednesday, August 16th. Leerink Partnrs analyst J. Schwartz now expects that the company will post earnings of ($1.05) per share for […]
Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report)’s stock price fell 4.6% during mid-day trading on Monday . The stock traded as low as $4.43 and last traded at $4.52. 10,409 shares were traded during mid-day trading, a decline of 66% from the average session volume of 30,468 shares. The stock had previously closed at […]
Finepoint Capital LP acquired a new position in Solid Biosciences Inc. (NASDAQ:SLDB – Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 218,562 shares of the company’s stock, valued at approximately $1,176,000. Solid Biosciences makes up approximately 0.4% of Finepoint Capital […]
Solid Biosciences (NASDAQ:SLDB – Get Rating) and Arcellx (NASDAQ:ACLX – Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability. Volatility and Risk Solid Biosciences has a beta of 1.47, indicating […]
Solid Biosciences (NASDAQ:SLDB – Get Rating) and Arcellx (NASDAQ:ACLX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Risk & Volatility Solid Biosciences has a beta of 1.47, […]